approval
saveTOPIRAMATE — FDA approval
community read0 votes
Sponsor: GLENMARK PHARMS LTD. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalEPRONTIA (TOPIRAMATE) — FDA approvalMar 6, 2026 · 213d ago
- approvalTOPIRAMATE — FDA approvalJan 27, 2026 · 251d ago
- approvalTOPIRAMATE — FDA approvalJan 12, 2026 · 266d ago
- approvalTOPIRAMATE — FDA approvalDec 4, 2025 · 305d ago
- approvalTOPIRAMATE — FDA approvalOct 7, 2025 · 363d ago
- approvalEPRONTIA (TOPIRAMATE) — FDA approvalMar 12, 2025 · 572d ago
- approvalTOPIRAMATE — FDA approvalJul 16, 2024 · 811d ago
- approvalEPRONTIA (TOPIRAMATE) — FDA approvalMay 17, 2024 · 871d ago
same company · ±60 days · 5
- approvalFINGOLIMOD HYDROCHLORIDE: FINGOLIMOD HYDROCHLORIDE — FDA approvalJan 16, 2026
- approvalLACOSAMIDE — FDA approvalJan 21, 2026
- approvalSUCRALFATE: SUCRALFATE — FDA approvalJan 5, 2026
- approvaltopiramate ER: TOPIRAMATE — FDA approvalDec 4, 2025
- approvalFluticasone Propionate Glenmark: FLUTICASONE PROPIONATE — FDA approvalMar 16, 2026
comments(0)
5-min edit window · permanent after that